CEBPZ
(CCAAT/enhancer Binding Protein (C/EBP), zeta (CEBPZ))
Protein Region
Middle Region
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-CEBPZ antibody (Catalog #: ARP38680_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
CEBPZ
Reaktivität: Human, Ratte
Wirt: Synthetic
BP, BI
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
CEBPZ
(CCAAT/enhancer Binding Protein (C/EBP), zeta (CEBPZ))
Hintergrund
CEBPZ is a member of the CCAAT-binding transcription factor (CTF)/nuclear factor I (NF-I) group of cellular DNA-binding proteins that recognizes the sequence GCCAAT and is implicated in eukaryotic transcription, as well as DNA replication.
Alias Symbols: CBF2, HSP-CBF, NOC1, CBF
Protein Interaction Partner: LAG3,NFYB,TP53,TP73,NFYB,TP53,TP73